Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lamyropsis microcephala/seenevastane

Link salvestatakse lõikelauale
12 tulemused

Silymarin in COVID-19 Pneumonia

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
To date, there are no drugs or other therapeutics approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19 that has spread globally resulting in the ongoing pandemic as declared by the World Health Organization (WHO) on 11 March 2020. While the majority of patients have

Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Tumor heterogeneity leads to a significant difference in the rate of response to drugs in patients with the same pathological type. According to the information, the current initial effective rate of domestic and foreign chemotherapeutic single drug is no more than 30%, even if treated with repeated

Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This is an open-label single-dose study. Approximately 40 total subjects will be enrolled. In each of the 3 hepatic impairment groups (mild hepatic dysfunction [Child-Pugh score of 5 - 6], moderate hepatic dysfunction [Child-Pugh score of 7 - 9], severe hepatic dysfunction [Child Pugh score of 10 -

THISTLE - The HIV-HCV Silibinin Trial

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This study will look for possible protective effects silymarin on kidney injury in patients receiving cisplatin.

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Comparative Effects of Milk Thistle Extract With Vitamin-E in Hemodialysis Patients

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Prostate cancer is the most common invasive malignancy and the second leading cause of cancer death in American males. In 2005, an estimated 230,000 men will be diagnosed and 30,000 will die from prostate cancer. The current estimated risk of developing prostate cancer is 1 in 6 men. Carcinogenesis

An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BIOAVAILABILTY STUDY: 1. Clinical Protocol Screening/Informed Consent: Sixteen subjects will be recruited for the clinical protocol. All protocols, consent forms, and HIPAA forms shall be IRB-approved prior to initiating any study procedure or recruitment. At a screening/informed consent visit, the

Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background: IBS (Irritable Bowel Syndrome) is a disorder of motility of the entire GI tract that produces cramping, abdominal pain, constipation, and/or diarrhea and sometimes passing of mucus in bowel movements. In most people with IBS, the GI tract is highly sensitive to many stimuli, including

Evaluating Silymarin for Chronic Hepatitis C

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The objective of this exploratory project is to assess the feasibility of investigating the effect of silymarin, derived from the milk thistle plant, Silybum marianum, in preventing and reversing the complications of chronic infection with HCV and/or clearing HCV infections, thereby generating
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge